YU37478A - Process for preparing novel 2-amino-alkoxy-styrenes - Google Patents

Process for preparing novel 2-amino-alkoxy-styrenes

Info

Publication number
YU37478A
YU37478A YU00374/78A YU37478A YU37478A YU 37478 A YU37478 A YU 37478A YU 00374/78 A YU00374/78 A YU 00374/78A YU 37478 A YU37478 A YU 37478A YU 37478 A YU37478 A YU 37478A
Authority
YU
Yugoslavia
Prior art keywords
styrenes
alkoxy
amino
preparing novel
preparing
Prior art date
Application number
YU00374/78A
Inventor
Mueller Erich
Erich Mueller
Maier Roland
Roland Maier
Diederen Willi
Willi Diederen
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of YU37478A publication Critical patent/YU37478A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/18—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring
    • C07C39/19—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring containing carbon-to-carbon double bonds but no carbon-to-carbon triple bonds
    • C07C39/20—Hydroxy-styrenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Illuminated Signs And Luminous Advertising (AREA)
YU00374/78A 1969-08-05 1978-02-17 Process for preparing novel 2-amino-alkoxy-styrenes YU37478A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1939809A DE1939809B2 (en) 1969-08-05 1969-08-05 β-Aryl-2-aminoalkoxy-styrenes and process for their preparation

Publications (1)

Publication Number Publication Date
YU37478A true YU37478A (en) 1979-07-10

Family

ID=5741970

Family Applications (2)

Application Number Title Priority Date Filing Date
YU01981/70A YU198170A (en) 1969-08-05 1970-08-04 Process for preparing novel beta-aryl-2-aminoalkoxy-styrenes
YU00374/78A YU37478A (en) 1969-08-05 1978-02-17 Process for preparing novel 2-amino-alkoxy-styrenes

Family Applications Before (1)

Application Number Title Priority Date Filing Date
YU01981/70A YU198170A (en) 1969-08-05 1970-08-04 Process for preparing novel beta-aryl-2-aminoalkoxy-styrenes

Country Status (25)

Country Link
JP (6) JPS4941433B1 (en)
KR (1) KR780000113B1 (en)
AT (5) AT301565B (en)
BE (1) BE754405A (en)
BG (6) BG18600A3 (en)
CH (6) CH548366A (en)
CS (6) CS170536B2 (en)
DE (1) DE1939809B2 (en)
DK (1) DK139717B (en)
ES (6) ES382426A1 (en)
FI (1) FI54912C (en)
FR (1) FR2068463B1 (en)
GB (1) GB1307436A (en)
HU (1) HU163185B (en)
IE (1) IE34634B1 (en)
IL (1) IL35047A (en)
NL (1) NL7011590A (en)
NO (1) NO135243C (en)
PH (1) PH9520A (en)
PL (2) PL93130B1 (en)
RO (5) RO58837A (en)
SE (1) SE382211B (en)
SU (4) SU432712A3 (en)
YU (2) YU198170A (en)
ZA (1) ZA705411B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50139537A (en) * 1974-04-25 1975-11-07
US4220603A (en) * 1977-10-07 1980-09-02 Mitsubishi Chemical Industries, Limited Pharmaceutically active (omega-aminoalkoxy)bibenzyls
JPS6045632B2 (en) * 1978-03-09 1985-10-11 三菱化学株式会社 ω-aminoalkoxystilbenes and their acid addition salts
DE2818765A1 (en) 1978-04-28 1979-11-08 Basf Ag AMINO DERIVATIVES OF 2-METHYL-5- (2-HYDROXYSTYRENE) -1,3,4-THIADIAZOLE
DE2818998A1 (en) * 1978-04-29 1979-11-15 Basf Ag 3-ALKYL-5- (2-HYDROXY-STYRYL) -ISOXAZOLES AND METHOD FOR THE PRODUCTION THEREOF
DE2818999A1 (en) * 1978-04-29 1979-11-15 Basf Ag AMINO DERIVATIVES OF 3-ALKYL-5- (2-HYDROXYSTYRYL) -ISOXAZOLES
JPS5629548A (en) * 1979-08-16 1981-03-24 Mitsubishi Chem Ind Ltd Omega-aminoalkoxystilbenes and their acid addition salts
DE2943405A1 (en) 1979-10-26 1981-05-07 Basf Ag, 6700 Ludwigshafen NEW AMINO DERIVATIVES OF 5- (2-HYDROXYSTYRYL) -ISOXAZOLE
DE2943406A1 (en) 1979-10-26 1981-05-07 Basf Ag, 6700 Ludwigshafen AMINO DERIVATIVES OF 2-METHYL-5- (2-HYDROXYSTYRYL) -1,3,4-THIADIAZOL
DE3006809A1 (en) * 1980-02-23 1981-09-24 Basf Ag, 6700 Ludwigshafen 2 - ((3-AMINO-2-HYDROXY-PROPOXY) -STYRYL) -ISOXAZOLES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
JPS5874379U (en) * 1981-11-16 1983-05-19 富士通株式会社 electronic equipment
NZ213986A (en) * 1984-10-30 1989-07-27 Usv Pharma Corp Heterocyclic or aromatic compounds, and pharmaceutical compositions containing such
US9468566B2 (en) 2011-06-10 2016-10-18 The Procter & Gamble Company Absorbent structure for absorbent articles
SG195105A1 (en) 2011-06-10 2013-12-30 Procter & Gamble Absorbent core for disposable absorbent articles
CA3042501C (en) 2011-06-10 2020-06-23 The Procter & Gamble Company An absorbent core for disposable diapers comprising longitudinal channels
PL2740449T3 (en) 2012-12-10 2019-07-31 The Procter & Gamble Company Absorbent article with high absorbent material content
DE202014011155U1 (en) 2013-06-14 2018-03-07 The Procter & Gamble Company When wet, channels forming absorbent article and absorbent core
US9987176B2 (en) 2013-08-27 2018-06-05 The Procter & Gamble Company Absorbent articles with channels
EP3351225B1 (en) 2013-09-19 2021-12-29 The Procter & Gamble Company Absorbent cores having material free areas
ES2606320T3 (en) 2013-12-19 2017-03-23 The Procter & Gamble Company Absorbent cores that have channel-forming areas and wrapping joints in c

Also Published As

Publication number Publication date
PL78370B1 (en) 1975-06-30
CH548366A (en) 1974-04-30
DE1939809C3 (en) 1979-01-11
JPS4941433B1 (en) 1974-11-08
ES382428A1 (en) 1972-11-16
JPS5113147B1 (en) 1976-04-26
CH548983A (en) 1974-05-15
YU198170A (en) 1979-07-10
CS170537B2 (en) 1976-08-27
DK139717C (en) 1979-09-17
BG20095A3 (en) 1975-10-30
FI54912B (en) 1978-12-29
AT303055B (en) 1972-11-10
BG17951A3 (en) 1974-03-05
CS170536B2 (en) 1976-08-27
IL35047A (en) 1973-05-31
CS170534B2 (en) 1976-08-27
BG17950A3 (en) 1974-03-05
CH548367A (en) 1974-04-30
CS170535B2 (en) 1976-08-27
GB1307436A (en) 1973-02-21
AT301565B (en) 1972-09-11
FR2068463B1 (en) 1974-08-30
JPS5113150B1 (en) 1976-04-26
CS170533B2 (en) 1976-08-27
RO57548A (en) 1975-02-15
FI54912C (en) 1979-04-10
ES382429A1 (en) 1972-11-16
NL7011590A (en) 1971-02-09
RO57793A (en) 1975-03-15
ZA705411B (en) 1971-05-27
SU439966A3 (en) 1974-08-15
SU428597A3 (en) 1974-05-15
KR780000113B1 (en) 1978-04-15
PH9520A (en) 1976-01-09
AT302346B (en) 1972-10-10
AT302345B (en) 1972-10-10
SU432712A3 (en) 1974-06-15
CH548982A (en) 1974-05-15
CS170538B2 (en) 1976-08-27
FR2068463A1 (en) 1971-08-27
SE382211B (en) 1976-01-19
DE1939809A1 (en) 1971-02-18
RO57794A (en) 1975-06-15
JPS5113146B1 (en) 1976-04-26
ES382426A1 (en) 1972-11-16
DK139717B (en) 1979-04-02
NO135243C (en) 1977-03-09
BG18599A3 (en) 1975-02-25
ES382430A1 (en) 1972-12-01
RO58837A (en) 1975-09-15
DE1939809B2 (en) 1978-04-13
BG18600A3 (en) 1975-02-25
BE754405A (en) 1971-02-04
JPS5113149B1 (en) 1976-04-26
IE34634L (en) 1971-02-05
SU439965A3 (en) 1974-08-15
CH548368A (en) 1974-04-30
JPS5113148B1 (en) 1976-04-26
HU163185B (en) 1973-06-28
SU450398A3 (en) 1974-11-15
ES382425A1 (en) 1972-11-16
BG17952A3 (en) 1974-03-05
RO58861A2 (en) 1975-06-30
PL93130B1 (en) 1977-05-30
AT302344B (en) 1972-10-10
ES382427A1 (en) 1972-11-16
CH548981A (en) 1974-05-15
NO135243B (en) 1976-11-29
IE34634B1 (en) 1975-07-09
IL35047A0 (en) 1970-10-30

Similar Documents

Publication Publication Date Title
YU294570A (en) Process for preparing delta-alkylamino-propiophenones
YU198170A (en) Process for preparing novel beta-aryl-2-aminoalkoxy-styrenes
YU254475A (en) Process for preparing novel 1-phenoxy-2-hydroxy-3-cycloalkyl-aminopropanes
YU137878A (en) Process for preparing naphthylalkylamines
YU238570A (en) Process for obtaining amino-alshols
YU303970A (en) Process for preparing novel evomonoside derivatives
YU27870A (en) Process for preparing novel antibiotics
YU33975B (en) Process for preparing bufatrienolide-rhamnoside-acylates
YU181070A (en) Process for preparing novel dialkylamino-alkanoyl amides
YU201378A (en) Process for obtaining 3-amino-delta2-pyrazoline
YU39070A (en) Process for preparing novel substituted o-anilino-pheneth
YU137270A (en) Process for preparing thiamphenicol-glycinate acetylcysteinate
YU35116B (en) Process for obtaining novel dimethylaminopropylthiocarbamates
YU34475B (en) Process for preparing 5-hydroxy-or 6-hydroxy-isoquinuclidines
YU144670A (en) Process for preparing substituted shloroacylanilides
YU34037B (en) Process for preparing novel p-amino-alkylbenzene-sulfonamide derivatives
YU140970A (en) Process for preparing novel substituted 5-nitro-2-furfurylidene-amino-oxazolidinones
YU183570A (en) Process for preparing 3-chloro-4-n-and-iso-propoxy-ureas
YU201270A (en) Process for preparing phenyl-3-tert.-butyl-5-oxadiazolone-2
YU254775A (en) Process for preparing novel 1-phenoxy-2-hydroxy-3-cycloalkyl-aminopropanes
YU167369A (en) Process for preparing 9delta-fluoro-16-methylene-prednisolone-21-acetate
CS194181B2 (en) Process for preparing beta-anilino-alpha-benzyl-acrylonitriles